2012 Annual Meeting | Neuromuscular Junction Disorders

Date Saturday 04/21/12

Time 08:00 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Robert M. Pascuzzi, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders; learn to critically select therapies; and be able to distinguish myasthenia gravis, MuSk myasthenia and Lambert-Eaton syndrome.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic

Program Evaluations

Event Timeline
08:00 AM - 08:05 AM		Intrduction and Course Overview Robert M. Pascuzzi, MD, FAAN
08:05 AM - 08:55 AM		Myasthenia Gravis: Clinical Presentation and Confirming the Diagnosis Janice M. Massey, MD, FAAN
08:55 AM - 09:45 AM		Treatment of Myasthenia Gravis Richard J. Barohn, MD, FAAN
09:55 AM - 10:10 AM		Break
10:10 AM - 11:00 AM		Toxins and Disorders of Neuromuscular Transmission (Botulism, Organophosphate Poisoning, Tick Paralysis) Laura M. Tormoehlen, MD, FAAN
11:00 AM - 11:50 AM		Lambert-Eaton Syndrome and the Less Common Disorders of Neuromuscuar Transmission Robert M. Pascuzzi, MD, FAAN
11:50 AM - 12:00 PM		Discussion

Faculty Disclosures
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Janice M. Massey, MD, FAAN	Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Robert M. Pascuzzi, MD, FAAN	Dr. Pascuzzi has nothing to disclose.
Laura M. Tormoehlen, MD, FAAN	The institution of Dr. Tormoehlen has received research support from Genentech. Dr. Tormoehlen has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��